Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is looking at the safety and tolerability of TNFeradeä Biologic combined with
conventional once daily radiation therapy in elderly or frail patients with new onset locally
advanced head and neck tumors.